Amalgamated Bank’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,512
Closed -$441K 2998
2023
Q4
$441K Buy
7,512
+699
+10% +$41K ﹤0.01% 1489
2023
Q3
$297K Sell
6,813
-18
-0.3% -$785 ﹤0.01% 1634
2023
Q2
$247K Sell
6,831
-301
-4% -$10.9K ﹤0.01% 1741
2023
Q1
$265K Sell
7,132
-1,069
-13% -$39.7K ﹤0.01% 1694
2022
Q4
$372K Buy
8,201
+369
+5% +$16.7K ﹤0.01% 1599
2022
Q3
$547K Buy
7,832
+78
+1% +$5.45K 0.01% 1384
2022
Q2
$521K Sell
7,754
-1,538
-17% -$103K ﹤0.01% 1443
2022
Q1
$764K Buy
9,292
+742
+9% +$61K 0.01% 1339
2021
Q4
$1.25M Buy
8,550
+1,439
+20% +$211K 0.01% 1140
2021
Q3
$1.26M Sell
7,111
-422
-6% -$74.7K 0.01% 1134
2021
Q2
$1.22M Buy
7,533
+1,442
+24% +$233K 0.01% 1188
2021
Q1
$1.04M Sell
6,091
-587
-9% -$101K 0.04% 535
2020
Q4
$1.47M Buy
6,678
+843
+14% +$185K 0.06% 356
2020
Q3
$969K Sell
5,835
-48
-0.8% -$7.97K 0.04% 465
2020
Q2
$672K Buy
5,883
+782
+15% +$89.3K 0.03% 651
2020
Q1
$392K Buy
5,101
+206
+4% +$15.8K 0.01% 1019
2019
Q4
$631K Buy
4,895
+473
+11% +$61K 0.01% 1000
2019
Q3
$345K Sell
4,422
-60
-1% -$4.68K 0.01% 1233
2019
Q2
$462K Buy
4,482
+1,245
+38% +$128K 0.01% 1111
2019
Q1
$237K Buy
+3,237
New +$237K 0.01% 1413